Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-017427
Filing Date
2017-06-28
Accepted
2017-06-28 19:28:35
Documents
2
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 11304
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4650
  Complete submission text file 0000899243-17-017427.txt   17294
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address
Kapnick Scott (Reporting) CIK: 0001709654 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 17936484